We are live on
!
Find out more
KFO
Kopp Family Office Portfolio holdings
AUM
$163M
1-Year Est. Return
22.57%
This Fund
S&P 500
This Quarter
Est. Return
+11.24%
1 Year Est. Return
+22.57%
3 Year Est. Return
+33.98%
5 Year Est. Return
+1.93%
10 Year Est. Return
–
AUM
$163M
AUM Growth
+$17.8M
(+12%)
Cap. Flow
+$3.13M
Cap. Flow
% of AUM
1.92%
Top 10 Holdings %
Top 10 Hldgs %
89.37%
Holding
30
New
9
Increased
10
Reduced
7
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$6.16M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$2.68M |
| 3 |
Shopify
SHOP
|
+$1.35M |
| 4 |
CBLL
CeriBell Inc
CBLL
|
+$656K |
| 5 |
Universal Technical Institute
UTI
|
+$653K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vericel Corp
VCEL
|
+$4.04M |
| 2 |
Xometry
XMTR
|
+$2.63M |
| 3 |
Hawkins
HWKN
|
+$2.42M |
| 4 |
Viridian Therapeutics
VRDN
|
+$1.08M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$73.1K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.59% |
| 2 | Healthcare | 5.07% |
| 3 | Industrials | 2.32% |
| 4 | Materials | 1.01% |
| 5 | Consumer Staples | 0.88% |
Similar funds
OFM
PCR
TCGDR
IPWA
IVGAI
CC
GP
PWAM
Kopp Family Office's Q2 2026 Portfolio in Review
As of Q2 2026, Kopp Family Office held 30 positions worth $163M, up 12% from $145M the previous quarter. Its ten largest holdings account for 89% of the portfolio.
Kopp Family Office's Q2 2026 filing shows 9 new, 10 increased, 7 reduced and 1 closed positions. Its largest new stake was State Street Utilities Select Sector SPDR ETF: 59,245 shares worth $2.69M. The largest sale was Vericel Corp, an estimated $4.04M.
By sector, the portfolio is most concentrated in Technology at 6.6% of assets, up from 6.2% a quarter earlier, followed by Healthcare and Industrials.
- Kopp Family Office's largest Q2 2026 buy was State Street Utilities Select Sector SPDR ETF: 59,245 shares worth $2.69M.
- Kopp Family Office added most to iShares Core US Aggregate Bond ETF in Q2 2026, an estimated $6.16M increase.
- Kopp Family Office's biggest Q2 2026 reduction was Vericel Corp, cutting an estimated $4.04M.
- Kopp Family Office fully exited Viridian Therapeutics in Q2 2026, selling an estimated $1.08M.
- Kopp Family Office's ten largest holdings make up 89% of its $163M portfolio in Q2 2026.
- Kopp Family Office opened 9 new positions and closed 1 in Q2 2026.
- Kopp Family Office's portfolio value rose 12% quarter-over-quarter to $163M.
Based on Kopp Family Office's 13F filing for Q2 2026, filed 9 Jul 2026.